Technical Analysis for AVGR - Avinger, Inc.
|Grade||Last Price||% Change||Price Change|
AVGR closed up 3.57 percent on Friday, January 18, 2019, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Down||Down||Down|
|See historical AVGR trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 17||50 DMA Resistance||Bearish||3.57%|
|Jan 17||Wide Bands||Range Expansion||3.57%|
|Jan 16||Fell Below 50 DMA||Bearish||3.57%|
|Jan 16||20 DMA Support||Bullish||3.57%|
|Jan 16||Wide Bands||Range Expansion||3.57%|
|Jan 16||Overbought Stochastic||Strength||3.57%|
|Jan 15||Bearish Engulfing||Bearish||-3.33%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Avinger, Inc., a medical device company, designs, manufactures, and sells image-guided, catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD). It offers Lightbox, an imaging console, which enables the use of lumivascular catheters during PAD procedures; Ocelot, a chronic total occlusion (CTO) crossing catheter, which allows physicians to see the inside of an artery during a CTO crossing procedure; Ocelot PIXL, a lower profile CTO-crossing device for below-the-knee arteries; and Ocelot MVRX, a device which offers a tip design for above-the-knee arteries. The company also provides Wildcat, a catheter that facilitates the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention; and Kittycat 2, a catheter that facilitate the intraluminal placement of conventional guidewires beyond stenotic lesions in the peripheral vasculature prior to further percutaneous intervention. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists directly in the United States and Europe. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more AVGR news...
|52 Week High||8.32|
|52 Week Low||0.18|
|200-Day Moving Average||1.0884|
|50-Day Moving Average||0.2939|
|20-Day Moving Average||0.2688|
|10-Day Moving Average||0.3015|
|Average True Range||0.0408|
|Chandelier Exit (Long, 3 ATRs )||0.2376|
|Chandelier Exit (Short, 3 ATRs )||0.3024|
|Upper Bollinger Band||0.3578|
|Lower Bollinger Band||0.1798|
|Percent B (%b)||0.62|
|MACD Signal Line||-0.0155|
|Market Cap||6.93 Million|
|Num Shares||23.9 Million|
|Price-to-Earnings (P/E) Ratio||-0.12|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||0.32|
|Resistance 3 (R3)||0.32||0.30||0.32|
|Resistance 2 (R2)||0.30||0.30||0.31||0.31|
|Resistance 1 (R1)||0.30||0.29||0.30||0.30||0.31|
|Support 1 (S1)||0.28||0.28||0.28||0.28||0.27|
|Support 2 (S2)||0.26||0.27||0.27||0.27|
|Support 3 (S3)||0.26||0.26||0.27|
|Support 4 (S4)||0.26|